The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
Weathergeek are you still holding SYME shares?
Explaining why the price hasn't moved is basically asking to explain volatility in the stock market. Far too many variables to give an accurate answer.
Instead trust your own research and character of the CEO then make your own decisions. Although criticising others for an indefinite answer is easier.
I can't be bothered to get into a spat with you as my time is more valuable. However just to clarify 1 RNS (without figures) can cause the SP to rise by almost 100% as it has in the past, contrary to your comment, which I have quoted below:
"Well, they market was not impressed with this RNS. The price is down. I doubt more RNS like this will help."
You have some what spared your embarrassment with such a vague statement which carries little weight for a rise or drop. As predicted.
If you bought in during July/ early August near the 0.003p range your almost looking at 100% profit at today's SP. Not to mention the growth of the company within the last 6 months, stated in RNS. So I'm happy to hold as opposed to risk trading daily.
For anyone who has been with SYME from July onwards, it is clear to see some RNS which don't mention figures cause a rise and some cause a drop. It's not a given that non numerical RNS would cause a fall in SP, instead a fact that caused a rise.
Feel confident in fact rather than guess work.
Last RNS mentioned SH is complete and legalities complete. AZ hasn't lied before so I believe him, jeez if I didn't I would just sell instead of argue on a BB.
Looking forward to UK update too, Brexit now complete should allow for further clarification as to standing.
Brilliant move by AZ IMO he has not promised something and let us down this year, he has outlined delays and kept to his word re funding partners, SH and Middle East.
So he has confirmed function and further positive sentiment, yet held back so far on names perhaps to avoid a sell off of RNS news. Instead investors will have to wait but without a heavy heart. Secondly sell at your own risk in early 21 as he may slam dunk an RNS outlining Middle East, UK, US etc
Excellent so the platform works, 2 of the big 4 have accepted it, funding is in place as mentioned in previous RNS and SYME is expected to grow in client number and repeat business of individual clients. Names to be given early 2021.
Can't ask for more really. Congratulations AZ and all SYME investors.